The shareholders’ right to decide on the Company’s affairs is exercised at its highest decision-making body - the general meeting (the annual general meeting or an extraordinary general meeting). The general meeting decides, for example, on changes to the articles of association, the election of the Board of Directors and auditors, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and the CEO, the appropriation of profit or loss, the principles for the appointment of the nomination committee and remuneration guidelines for senior executives.
General meetings shall be held in Lund. Notice convening the annual general meetings and extraordinary general meetings where amendments to the articles of association are to be addressed, shall be issued no earlier than six weeks and no later than four weeks prior to the meeting. Notice convening other extraordinary general meetings shall be issued no earlier than six weeks and no later than three weeks prior to the meeting. Notice shall be published in the Swedish National Gazette (Sw. Post- och Inrikes Tidningar) and by making the notice available on the Company’s website. Information regarding the notice shall at the same time be advertised in Dagens Industri.
Annual General Meeting 2018
The Annual General Meeting will be held Thursday 26 April at 4:00 pm CET at Medicon Village, Scheelevägen 2 in Lund.
A shareholder who wishes to have a matter considered by the Annual General Meeting on 26 April 2018 may submit a written request to Alligator's Chairman of the Board either on email: email@example.com or to the address Alligator Bioscience AB, att: Proposal for AGM, Medicon Village, 223 81 Lund. Proposals for the agenda shall be submitted no later than 8 March 2018 to be included in the notice convening the Annual General Meeting.